Cardinal Health Enters into Binding Letter of Intent to Extend Pharmaceutical Distribution Agreements with CVS Health
Cardinal Health signed a binding Letter of Intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, at the current scope of services. In connection with the renewal, the company reaffirmed fiscal 2027 non-GAAP EPS guidance of 13% to 15% growth ($12.40 to $12.60) and a long-term non-GAAP EPS growth rate of 12% to 14%.
Key figures
- Guidance
- FY2027 non-GAAP EPS growth of 13% to 15% ($12.40 to $12.60) reaffirmed; long-term non-GAAP EPS growth of 12% to 14%
- Contract end date
- June 30, 2032
- Fy27 eps guidance low
- 12.4
- Fy27 eps guidance high
- 12.6
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.